Magellan Health (Magellan Health) Earnings per Share (Diluted) : $11.47 (TTM As of Sep. 2021)

View and export this data going back to 2004. Start your Free Trial

What is Magellan Health Earnings per Share (Diluted)?

Magellan Health's Earnings per Share (Diluted) for the three months ended in Sep. 2021 was $0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 was $11.47.

Magellan Health's EPS (Basic) for the three months ended in Sep. 2021 was $0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2021 was $11.50.

Magellan Health's EPS without NRI for the three months ended in Sep. 2021 was $-0.20. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.34.

During the past 12 months, Magellan Health's average EPS without NRIGrowth Rate was -117.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -67.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -38.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -23.80% per year.

During the past 13 years, Magellan Health's highest 3-Year average EPS without NRI Growth Rate was 316.80% per year. The lowest was -67.10% per year. And the median was 0.95% per year.

Magellan Health Earnings per Share (Diluted) Historical Data

The historical data trend for Magellan Health's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magellan Health Earnings per Share (Diluted) Chart

Magellan Health Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Earnings per Share (Diluted)

Get a 7-Day Free Trial

3.22

4.51

0.97

2.27

14.98

Magellan Health Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Earnings per Share (Diluted)	Get a 7-Day Free Trial															0.46	10.43	1.04	-0.03	0.03

Competitive Comparison of Magellan Health's Earnings per Share (Diluted)

For the Healthcare Plans subindustry, Magellan Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Magellan Health's PE Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where Magellan Health's PE Ratio falls into.

Magellan Health Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Magellan Health's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2020 is calculated as

Diluted Earnings Per Share (A: Dec. 2020 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(382.335	-	0)	/	25.532
	=	14.97

Magellan Health's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2021 is calculated as

Diluted Earnings Per Share (Q: Sep. 2021 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(0.903	-	0)	/	26.247
	=	0.03

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.47

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Magellan Health (NAS:MGLN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Magellan Health Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Magellan Health's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Magellan Health (Magellan Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » Earnings per Share (Diluted)

Comparable Companies

GTS BFYT PFHO UNH CVS ANTM CI HUM CNC MOH BSP:GNDI3 BSP:ODPV3 SZSE:000503 BSP:QUAL3 ROCO:6665 MIL:HI OSTO:FEEL TSXV:NXG

Traded in Other Exchanges

N/A

Address

4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034

Website

https://www.magellanhealth.com

Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.

Executives

Mostafa Kamal	officer: CEO, Magellan Rx Management	15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West	officer: SVP & Controller	6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon	officer: Chief Financial Officer	6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld	director	201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott	director	4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone	director	C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie	director	NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen	director	4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson	director
James E Murray	officer: President and COO	500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis	officer: Chief Human Resources Officer	55 NOD ROAD AVON CT 06001
Kenneth J Fasola	director, officer: Chief Executive Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin	officer: Chief Financial Officer	55 NOD ROAD AVON CT 06001